Here are relevant reports on : biotechnology-reagent-market
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) & Region - Global Forecast to 2029
The global rapid microbiology testing market, valued at US$4.7 billion in 2023, stood at US$5.1 billion in 2024 and is projected to advance at a resilient CAGR of 10.1% from 2023 to 2029, culminating in a forecasted valuation of US$8.3 billion by the end of the period.The increasing use of rapid microbiology testing products can be attributed to their ability to provide quick and reliable results. These products are cost-effective and can often lead to cost savings compared to traditional methods, which is a significant factor driving market growth.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at USD13.06 billion in 2024, stood at USD14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.5billion by the end of the period. NGS platforms have undergone continuous technological innovations over the last several years.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030
The global healthcare data monetization market, valued at US$0.50 billion in 2024, stood at US$0.58 billion in 2025 and is projected to advance at a resilient CAGR of 14.9% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. The growth in this sector is driven by the increasing commercial value of real-time patient data, a growing emphasis on data-driven decision-making in life sciences, and the rise of data-as-a-service (DaaS) business models within healthcare.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
HPC Data Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing), Applications (NGS, Microscopy, Chromatography), End User (Pharmaceutical & Biotechnology, Hospitals) - Global Forecast to 2024
The HPC Data Management Market in life sciences is projected to reach USD 41.1 billion by 2024, at a CAGR of 17.1%. The growth of this market is majorly driven by the growing demand for data storage and management solutions due to extensive amount of data generated through large number of research activities. However, the high cost of implementation and regulatory hurdles are major factors restraining the growth of this market.Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (US), Cray, Inc. (US), Cisco Systems, Inc. (US), IBM Corporation (US), Intel Corporation (US), Lenovo Group Limited (China), Hewlett Packard Enterprise Company (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Healthcare RFID Market by Product (RFID tags, RFID readers, RFID printers), Application (tracking, monitoring), End User (Pharmaceutical and Biotechnology Companies, Hospitals) - Analysis and Global Forecasts to 2021
Radio-Frequency Identification (RFID) uses radio waves to read and capture information stored on a tag attached to an object. This tag can be read from several feet distance and does not need to be within direct line-of-sight of the reader. In healthcare industry, RFID technology can be used in supply chain applications, patient safety, and in quality assurance applications. RFID can be deployed in hospitals and clinics to improve patient flow, reduce medial errors, improve asset utilization rates, and mange inventories & implants, among others.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
